Tolmar Inc.
Clinical trials sponsored by Tolmar Inc., explained in plain language.
-
Breast cancer patients monitored for 4 years in safety extension trial
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a drug called TOL2506 in people with a type of breast cancer that is fueled by hormones. It includes premenopausal women and men who have already finished a previous study. Participants will continue taking TOL2506 along with other horm…
Phase: PHASE3 • Sponsor: Tolmar Inc. • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
New injection could help premenopausal women fight breast cancer
Disease control OngoingThis phase 3 study tests a 3-month injection (TOL2506) to temporarily stop ovarian function in premenopausal women with HR+, HER2- breast cancer. The goal is to lower hormones that can fuel cancer growth. About 250 participants will receive the injection along with standard hormo…
Phase: PHASE3 • Sponsor: Tolmar Inc. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New study checks if testosterone drug JATENZO harms adrenal glands
Knowledge-focused OngoingThis study looks at whether JATENZO, a testosterone replacement drug, affects adrenal gland function in men with low testosterone. About 110 men aged 18 to 65 will take JATENZO for 12 months and have their adrenal function tested. The goal is to see if the drug causes adrenal ins…
Phase: PHASE4 • Sponsor: Tolmar Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC